Breaking News

Samabriva Opens New Biomanufacturing Facility in Belgium

Will provide industrial-scale production of high-value natural molecules used in the manufacture of pharmaceutical products.

Author Image

By: Charlie Sternberg

Associate Editor

French biotechnology company Samabriva has opened a new 1,400 m² biomanufacturing facility in Liege, Belgium, at the heart of European’s biotech valley—strengthening its position as a leading player in the region’s thriving biomanufacturing ecosystem.   This multi-million Euros investment is designed to provide industrial-scale production of high-value natural molecules used in the manufacture of pharmaceutical products. Equipped with Samabriva’s proprietary bioreactors, which have been specif...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters